Blog Post

News and events
1 MIN READ

CDK Inhibitors approved by PBAC but cost is still an issue 20 April 2018

Giovanna_BCNA's avatar
8 years ago

CDK Inhibitors approved by Pharmaceutical Benefits Advisory Committee (PBAC) but cost is still an issue

See the link below for further information
https://www.bcna.org.au/news/2018/04/cdk-inhibitors-approved-by-pbac-but-costs-still-an-issue/

Published 8 years ago
Version 1.0
No CommentsBe the first to comment
Related Content
I’ve started reading about this treatment as it has been recommended for me . One article firmly stated chocolate , alcohol and coffee were not recommended. Is that what you all understand?? I mean th...
8 years ago